Likewise, understanding normal aging as opposed to dementia or Alzheimer’s Disease may improve targeted therapies, especially since some nAChR subtypes have been shown to be sensitive to β-amyloid [34, 35]. This evidence concerns the gene CHRNA4 and early-onset autosomal dominant Alzheimer disease.